Structural and dielectric properties of iron doped barium strontium titanate for storage applications

Barium strontium titanate (BST) and iron doped barium strontium titanate (BSTF) ceramics with general formula (Ba0.5Sr0.5Ti1-yFeyO3) and different iron (Fe) contents were prepared by slow rate injection sol-gel technique. The phase analysis, morphology and dielectric properties of BSTFs were investigated. The phase analysis was carried out using XRD which revealed the crystallization of BSTF in perovskite structure with single phase. The Fe doped BST peaks shifted toward higher angles and the calculated crystallite size was 19 nm on average. The BSTF morphology was studied using TEM which showed that the particle size was affected by Fe content. The average particle size was found to be 37 nm for (Ba0.5Sr0.5Ti1-yFeyO3) with Fe concentration of (y = 0.01, 0.05 and 0.1) calcined at (600, 800 and 1000 A degrees C). The dielectric measurements were carried out using impedance analyzer at room temperature as a function of frequency in the range of 10 Hz to 1 MHz. The dielectric constant and dielectric loss of the 1 mol% Fe-doped Ba0.5Sr0.5TiO3 at 1 kHz were 1453.69 and 0.0063, respectively. The BSTF ceramics with high dielectric constant and low dielectric loss were obtained for the application DRAM cell capacitor

Translating reference doses into allergen management practice: Challenges for stakeholders

Risk assessment describes the impact of a particular hazard as a function of dose and exposure. It forms the foundation of risk management and contributes to the overall decision-making process, but is not its endpoint. This paper outlines a risk analysis framework to underpin decision-making in the area of allergen cross-contact. Specifically, it identifies challenges relevant to each component of the risk analysis: risk assessment (data gaps and output interpretation); risk management (clear and realistic objectives); and risk communication (clear articulation of risk and benefit). Translation of the outputs from risk assessment models into risk management measures must be informed by a clear understanding of the model outputs and their limitations. This will lead to feasible and achievable risk management objectives, grounded in a level of risk accepted by the different stakeholders, thereby avoiding potential unintended detrimental consequences. Clear, consistent and trustworthy communications actively involving all stakeholders underpin these objectives. The conclusions, integrating the perspectives of different stakeholders, offer a vision where clear, science-based benchmarks form the basis of allergen management and labelling, cutting through the current confusion and uncertainty. Finally, the paper recognises that the proposed framework must be adaptable to new and emerging evidence

Translating reference doses into allergen management practice: Challenges for stakeholders

Risk assessment describes the impact of a particular hazard as a function of dose and exposure. It forms the foundation of risk management and contributes to the overall decision-making process, but is not its endpoint. This paper outlines a risk analysis framework to underpin decision-making in the area of allergen cross-contact. Specifically, it identifies challenges relevant to each component of the risk analysis: risk assessment (data gaps and output interpretation); risk management (clear and realistic objectives); and risk communication (clear articulation of risk and benefit). Translation of the outputs from risk assessment models into risk management measures must be informed by a clear understanding of the model outputs and their limitations. This will lead to feasible and achievable risk management objectives, grounded in a level of risk accepted by the different stakeholders, thereby avoiding potential unintended detrimental consequences. Clear, consistent and trustworthy communications actively involving all stakeholders underpin these objectives. The conclusions, integrating the perspectives of different stakeholders, offer a vision where clear, science-based benchmarks form the basis of allergen management and labelling, cutting through the current confusion and uncertainty. Finally, the paper recognises that the proposed framework must be adaptable to new and emerging evidence

Multi-scale simulation method for electroosmotic flows

Electroosmotic transport in micro-and nano- channels has important applications in biological and engineering systems but is difficult to model because nanoscale structure near surfaces impacts flow throughout the channel. We develop an efficient multi-scale simulation method that treats near-wall and bulk subdomains with different physical descriptions and couples them through a finite overlap region. Molecular dynamics is used in the near-wall subdomain where the ion density is inconsistent with continuum models and the discrete structure of solvent molecules is important. In the bulk region the solvent is treated as a continuum fluid described by the incompressible Navier-Stokes equations with thermal fluctuations. A discrete description of ions is retained because of the low density of ions and the long range of electrostatic interactions. A stochastic Euler-Lagrangian method is used to simulate the dynamics of these ions in the implicit continuum solvent. The overlap region allows free exchange of solvent and ions between the two subdomains. The hybrid approach is validated against full molecular dynamics simulations for different geometries and types of flows